InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,473.43
(
-0.25%
)
US TECH 100
19,305.52
(
-0.53%
)
Dow Jones
38,948.83
(
0.29%
)
Brent Oil
84.84
(
0.17%
)
Bitcoin
64,834.43
(
-0.20%
)
Post# of 252259
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 834
Posts 119875
Boards Moderated 17
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 150810

Thursday, 10/18/2012 3:38:25 PM

Thursday, October 18, 2012 3:38:25 PM

Post# of 252259
Re: Solanezumab survey post-mortem

I’m surprised that only 16 people voted in a survey on such a high-profile program that addresses what is probably the greatest unmet need in medicine today. I surmise that there would have been considerably more interest in this survey if a small biotech firm rather than a Big Pharma owned the rights to the drug.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up